Junshi Biosciences (also known as JUNSHI BIO) has announced it will hold a conference call to discuss its 2026 interim financial results on September 14, 2026.
According to the company's latest announcement, the event is scheduled to take place from 10:00 AM to 11:00 AM on that date. The call will provide investors with an opportunity to review the company's performance for the first half of 2026 and engage with management regarding the results.
The announcement was made on September 4, and the company is expected to address key operational and financial highlights during the session.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments